Nanoscience and Nanotechnology Commons^™

Neoadjuvant Therapy For Ovarian Cancer Using Bioglycogentm Nanoparticles Sbir Grant Proposal, Alexander E. Talamo

Nanoscale Science & Engineering (discontinued with class year 2014)

Project Summary Technical Abstract This Small Business Innovation Research Phase I project, presented by Talamo Inc., is to test an ovarian cancer therapeutic delivery system, comprised of a nanoscale biocompatible vesicle that carries a bioactive small interfering RNA molecule (siRNA), in vivio in mice. The siRNA has shown to reduce the expression of an enzyme (Sod2) that is highly expressed in multiple ovarian cancer types. The reduced expression of Sod2 will allow the tumor to become increasingly susceptible to chemotherapy agents, while simultaneously diminishing tumor progression. Research has proved that the nanoscale vesicle is non-toxic and in combination with siRNA …